Direct compression of Jidan Powder into veterinary tablets requires a particle size distribution in which D50 remains close to 120 µm and fines below 45 µm are held below 15% w/w. A 100 kg production blend is prepared by sieving Jidan Powder together with microcrystalline cellulose PH102 (25.0% w/w), spray-dried lactose monohydrate (55.0% w/w), crospovidone (4.0% w/w), and colloidal silicon dioxide (0.5% w/w) through a 1.0 mm oscillating sieve. The sieved mass is mixed in a 600 L bin blender at 10 rpm for 18 min, after which magnesium stearate (1.2% w/w) is added during the final 3 min at 6 rpm. Prolonged lubrication beyond 5 min increases tablet disintegration time above 15 min in water at 37.0 ± 0.5 °C per USP <701>, delaying release in swine gastric fluid. The terminal compressed unit is a 500 mg tablet containing 80 mg Jidan Powder, with hardness maintained at 70–90 N and friability below 0.8% on a PTF 20E tester. Assay release is performed by HPLC according to Ph. Eur. 2.2.29, with acceptance limits of 95.0–105.0% of label claim.

Scale-up failure on rotary presses occurs when turret speed exceeds 65,000 tablets/h and the API fraction contains more than 15% w/w of particles below 45 µm, because the fine fraction migrates through the paddle feeder and produces weight variation above 3.0% RSD. Reducing the API particle size improves content uniformity but shifts blend angle of repose above 38° unless colloidal silicon dioxide is increased to 0.8% w/w. On a Korsch XL 400 fitted with 10 mm round tooling and an 8-station paddle feeder, observed batch-to-batch weight variation under 22 ± 2 °C and 30–40% relative humidity is below 1.8% RSD when feeder speed is set to 45 rpm and die table speed is matched to 55,000 tablets/h. In-process checks every 30 min cover average weight, individual weight, hardness, thickness, and content uniformity according to USP <905>. For veterinary oral tablets, GMP requirements follow 21 CFR 211 and EU GMP Annex 5. Cleaning validation complies with 21 CFR 211.67, with residual API acceptance limits not exceeding 10 ppm in the next product. The finished dosage form is packed in thermoformed PVC/PVDC blisters containing 10 tablets per cavity and stored below 25 °C in sealed aluminum pouches.

Injectable Formulation of Jidan Powder Demands Terminal Sterilization and Endotoxin Controls That Are Not Applied to Feed-Grade Premixes

Injectable Jidan Powder is dissolved in water for injection in a stainless-steel vessel with bottom-mounted magnetic stirring. The target concentration is 100 mg/mL active equivalent, with pH adjusted to 4.5–5.5 using 1 N hydrochloric acid or 1 N sodium hydroxide. Osmolality is adjusted to 280–320 mOsmol/kg with sodium chloride, and the bulk solution is filtered through a 0.22 µm PVDF membrane into a sterile holding tank. Filling is performed on a Bausch & Strobel vial filling and stoppering line at 8,000 vials/h using 100 mL glass vials. Terminal sterilization by moist heat at 121 °C for 15 min is selected only after confirming that degradant formation remains below 0.2% peak area, because the API exhibits pH-dependent hydrolysis above 6.0. Each vial is sealed with a chlorobutyl rubber stopper and aluminum flip-off seal.

Injectable manufacturing is not interchangeable with oral-grade Jidan Powder processing. Oral-grade powder may contain bioburden up to 10,000 CFU/g, while injectable-grade material must meet Ph. Eur. 5.1.1 microbial quality. Terminal filtration is insufficient when pre-sterilization bioburden exceeds 100 CFU/100 mL. Pyrogen removal is not achieved by autoclaving. Glass contact surfaces on the filling line are depyrogenated by dry heat at 250 °C for 60 min. The terminal product is a sterile aqueous injection for intramuscular administration, with dose volume calculated per kilogram body weight according to the veterinary prescription. Batch records document holding time between final filtration and autoclaving, and any delay beyond 4 h requires re-evaluation of bioburden and bacterial endotoxins.

Capsule filling of Jidan Powder on an intermittent-motion machine requires the blend to maintain a Carr index between 18% and 28% because high fines content collapses the powder column in the dosator. A 100 kg capsule blend is prepared by mixing Jidan Powder (12.0% w/w), lactose monohydrate 200 mesh (62.0% w/w), pregelatinized starch (20.0% w/w), sodium starch glycolate (4.0% w/w), and magnesium stearate (2.0% w/w) in a V-blender for 20 min at 15 rpm. The filled size 0 hard gelatin capsule contains 100 mg Jidan Powder, with fill weight controlled at 420–440 mg. Capsule disintegration is tested in 900 mL of 0.1 N hydrochloric acid at 37.0 ± 0.5 °C; the dosage form must disintegrate within 30 min according to USP <711>. Capsule shell moisture is maintained at 13–16% w/w to avoid cracking on the filling line.

A common batch failure in gelatin capsule filling occurs when the blend is over-lubricated with magnesium stearate above 2.5% w/w, causing prolonged disintegration and slower dissolution. Because Jidan Powder is a cation-sensitive API, the formulation must not contain sodium lauryl sulfate above 1.0% w/w, because this increases the proportion of free drug in solution and may produce a lag in release. The production line is equipped with a Capsugel model 10,000 filling machine, and each batch is sampled at 20-minute intervals for fill weight. Published data for this specific formulation configuration is limited, so process qualification relies on the supplier CoA and in-house stability lots. The terminal product is a companion animal oral capsule, packed in HDPE bottles with a silica gel desiccant and induction-sealed closure; the pack is labelled for dose-by-bodyweight administration with feed.

What Limits the Addition Rate of Jidan Powder to Drinking Water Systems Without Precipitation?

Soluble powder for drinking water requires particle size below 180 µm and a wetting agent level that does not create excessive foaming. The powder is prepared by blending Jidan Powder (20.0% w/w) with anhydrous glucose (78.0% w/w) and silica dioxide (2.0% w/w) in a ribbon mixer at 25 rpm for 30 min. The resulting product is packed into 1 kg and 5 kg laminated foil pouches. Before field use, the sachet content is dissolved in 10 L of lukewarm water at 25–30 °C and then mixed into a 1,000 L header tank. Final drinking water concentration is 50–100 mg/L active ingredient, depending on the target species and withdrawal period. Continuous dosing requires a proportional dispenser calibrated to deliver 1 L stock solution per 100 L drinking water, with an accuracy of ±5%.

The limiting process parameter in hard water is pH and carbonate hardness. At total hardness above 250 ppm as CaCO₃, the API solution may undergo precipitation if pH rises above 7.0. Operators must pre-buffer the stock solution with citric acid 0.5–1.0 g/L to keep pH between 4.0 and 4.5. Incompatibility with chlorine-based disinfectants at residual free chlorine above 2 ppm reduces assay by more than 5% within 6 h; the drinking water line should be flushed and refilled after chlorination cycles. Field stability data show that at 25 °C and 60% relative humidity, the foil pack retains 98% of label claim after 12 months when moisture content remains below 1.0% w/w. The terminal product is a water-dispersible oral solution for poultry and swine, administered through the drinking water system under veterinary supervision.

Granulation of Jidan Powder for oral dosing in young pigs is performed in a top-spray fluid-bed dryer with Wurster insert. The granulation liquid is prepared by dissolving polyvinylpyrrolidone K30 at 5.0% w/w of dry granulate in purified water to form a 10% w/w binder solution. Spray rate is set to 80 g/min, inlet air temperature 60 °C, product bed temperature 32–36 °C, and atomizing air pressure 2.5 bar. After spraying, granules are dried until loss on drying is <2.0% w/w. The dry granulate is passed through a 1.0 mm conical mill with a round impeller at 900 rpm. Fines below 75 µm must be less than 15% w/w; if exceeded, segregation occurs during packaging and dosage cup filling. The final granule contains 50 mg/g Jidan Powder, with bulk density of 0.58–0.65 g/mL and a Hausner ratio below 1.25.

Granule sachet filling is performed on a vertical form-fill-seal machine with auger dosing. A line speed of 40 sachets/min requires the granulate to have a flow of 25–35 g/s through a 15 mm funnel. Batch records from production runs show that when inlet air humidity exceeds 60% RH, the granulate picks up moisture and blocks the auger, causing fill weight variation above 5.0% RSD. The solution is to precondition the granulation suite to 22 °C and 35–40% RH. The finished product is an oral granule in single-dose sachets containing 2 g of granulate, reconstituted at the farm in feed or water before administration. Approval for this dosage form requires demonstration of stability under accelerated conditions 40 ± 2 °C and 75 ± 5% RH for 6 months per VICH GL 3.

Premix Carrier Loading and Blend Uniformity in Ribbon Mixers

Premix manufacturing for medicated feed integrates Jidan Powder at a lower concentration to allow downstream dilution. A 5% w/w veterinary premix is prepared by first layering Jidan Powder (5.0% w/w) onto soybean meal carrier (85.0% w/w) in a 1,500 L ribbon mixer, then adding mineral oil (3.0% w/w) as a dust suppressant and colloidal silica (2.0% w/w) as a flow aid. Mixing time is 20 min at 20 rpm with a planetary action impeller; sampling is performed at 10 locations using a grain probe. Blend uniformity acceptance is 90.0–110.0% of theoretical content with RSD ≤ 5.0%, per FDA medicated feed compliance policy guides. The premix is packed in 25 kg multi-wall paper bags with inner polyethylene liner, sealed against moisture ingress.

Carrier selection is not a trivial diluent decision; soybean meal offers surface roughness that retains the fine Jidan Powder, but its moisture content must remain below 12% w/w to avoid mold growth. If corncob grit is used as an alternative carrier, the API load must be reduced to 2.5% w/w because the lower bulk density of corncob increases segregation potential. The final premix is blended with complete feed at 10 kg/tonne to deliver the veterinary active dosage according to the species-specific label. Homogeneity in the final feed is confirmed by a Type A medicated article check using HPLC with UV detection; coefficient of variation should not exceed 10% across 12 sampling points. The product is supplied to licensed feed mills only, under 21 CFR 558 and the relevant VICH stability guideline.

When Jidan Powder Is Formulated as an Oral Drench Solution for Neonatal Ruminants, Viscosity and Syringeability Override Bulk Powder Flow Considerations

The oral drench solution uses a solvent system of propylene glycol (30% v/v), glycerol (10% v/v), and purified water (60% v/v). Jidan Powder is dissolved at 20 mg/mL with continuous agitation at 200 rpm at 25 °C until the solution clears. pH is maintained at 5.0–5.5 with citrate buffer 0.05 M. The solution is filtered through a 75 µm strainer and filled into 500 mL HDPE dosing bottles with a calibrated draw-off cap. Syringeability is determined with a 20 mL syringe fitted with a 16-gauge needle; the solution must pass through with a force not exceeding 5 N. Viscosity at 20 °C is controlled at 25–45 mPa·s, because higher viscosity causes inaccurate dosing in cold weather at 4 °C.

For oral drench stability, the main degradation route is oxidative degradation in the presence of trace metals. Disodium edetate is added at 0.05% w/v as a chelator; ascorbic acid is not used because it accelerates browning at pH >5.0. The product is packaged in amber HDPE bottles to limit light-induced photodegradation. Photostability testing under ICH Q1B Option 2 is required, with assay loss not more than 5.0% after 1.2 million lux-h and 200 W h/m². The terminal product is an oral drench for neonatal calves and lambs, with a dose of 1 mL/10 kg body weight. The manufacturing line is cleaned with 0.5 M sodium hydroxide solution followed by a 1.0% phosphoric acid rinse to prevent cross-contamination.